Elutia Receives $8M Escrow Release from Boston Scientific, Extending Runway

Key Facts

1Elutia received the full $8 million held in escrow related to the sale of its BioEnvelope business to Boston Scientific.

2The company stated it is now fully funded into 2029, covering the first year of the expected NXT-41x launch.

Elutia received the full $8 million held in escrow by Boston Scientific Corporation. GlobeNewswire reported that the payment relates to the previous sale of Elutia's BioEnvelope business and marks the company's third major funding catalyst in 2026.

The company stated it is now fully funded into 2029, a period that includes the first year of the expected NXT-41x product launch. Regarding market performance, ELUT shares closed at $0.79 on September 30, 2026, while BSX shares closed at $43.65 on the same date.